Nasal and Paranasal Tumors

Nasal and paranasal tumors is a broad term used for masses arising from the nasal cavity and the air-filled sinus cavities surrounding the nose. Not all of these tumors are cancers; they may be benign, borderline in behavior, or malignant. In clinical practice, however, the group of greatest concern is malignant tumors developing in the nasal cavity and paranasal sinuses. The National Cancer Institute notes that cancers in this region are classified among head and neck cancers and that squamous cell carcinoma is the most common type. ^[1][2]

The anatomy of this region can cause symptoms to begin insidiously. In the early stage, masses may mimic ordinary sinusitis, unilateral nasal blockage, or intermittent nosebleeds. As the tumor enlarges, symptoms such as facial pressure, fullness in the cheek, foul-smelling unilateral discharge, swelling around the eye, numbness in the teeth, or headache may become more prominent. The NCI emphasizes that some individuals may have no symptoms in the early phase and that symptoms often become noticeable only as the tumor grows. For this reason, prolonged complaints—especially those limited to one side—deserve more careful evaluation. ^[1][3]

Certain occupational exposures are particularly important among the risk factors. Long-term exposure to wood dust, leather dust, certain chemicals, and some industrial dusts has been reported to increase the risk of cancer of the nasal cavity and sinuses. Even so, the absence of a risk factor does not mean the disease cannot occur; likewise, having a risk factor does not mean a tumor will definitely develop. Clinical assessment should always be made in conjunction with the character of symptoms, examination findings, and imaging results. New unilateral symptoms in a person with occupational exposure should not be ignored. ^[1][3]

Nasal and paranasal tumors are histologically heterogeneous. In other words, not every tumor arises from the same type of cell or behaves in the same way. Although squamous cell carcinoma is the most common type, adenocarcinoma, melanoma, sarcoma, and some rare tumors can also occur in this region. This distinction matters because the treatment plan, expected spread pattern, and prognosis may vary according to tumor type. It is not correct to view all cases the same way simply because imaging reports mention “a mass in the sinus.” Definite diagnosis requires biopsy and pathological evaluation. ^[1][2]

The diagnostic process usually begins with an otolaryngology examination. Endoscopic assessment may be the first step in understanding the location and appearance of the lesion. Thereafter, imaging methods such as CT and MRI are used to assess extension into bony structures, the orbit, or adjacent tissues. Imaging alone, however, cannot define the tumor type; tissue diagnosis through biopsy is required. Additional evaluation may also be needed for cervical lymph nodes and distant spread. Because staging directly affects treatment selection and surgical planning, it is a critical part of the diagnostic process. ^[1][3]

Treatment is generally planned in a multidisciplinary manner. According to the NCI, surgery, radiotherapy, and chemotherapy may be used in different combinations in these patients. In some cases surgery is the main strategy, while in other stages radiotherapy or chemoradiotherapy may be more appropriate. Tumor type, location, stage, spread to adjacent structures, and the patient’s general health all determine which option takes priority. In other words, there is no single standard scenario for every malignant tumor arising from the nose and sinuses. Treatment decisions should be made by a team experienced in head and neck cancer care. ^[1]

When surgery is planned, the goal is not only to remove the tumor, but also to preserve functional outcomes such as breathing, speech, smell, and facial appearance whenever possible. Endoscopic approaches may be suitable for some patients, while more extensive tumors may require open surgery and reconstruction. Radiotherapy is an important tool, especially for local control; in some cases it is used after surgery, and in others as primary treatment. Chemotherapy may also be considered alone or in combination with radiotherapy. Nutritional support, oral care, speech and swallowing support, and psychosocial support are also part of the treatment course. ^[1][3]

In this disease group, complications may stem not only from the cancer itself but also from its treatment. Because of proximity to the eye region, visual problems, changes in facial sensation, disorders affecting the relationship between the oral and nasal cavities, and reduced quality of life may occur. Regular follow-up after treatment is necessary both for early detection of recurrence and for management of side effects. Because the nose and sinus region is anatomically complex, it is not safe to assume that “my symptoms have improved, so I no longer need follow-up.” Recurrent unilateral blockage, bleeding, or new facial asymmetry should prompt reassessment. ^[1][3]

A practical answer to the question of when to see a doctor is this: if unilateral nasal blockage lasts more than a few weeks, if there are unexplained nosebleeds, unilateral facial pain or pressure, swelling around the eye, double vision, facial numbness, or prolonged foul-smelling discharge, evaluation should not be delayed. Many of these symptoms may also occur in benign conditions; however, their persistence—especially on one side—broadens the differential diagnosis. Early evaluation may increase the chance of identifying a possible tumor at a more limited stage. ^[1][3]

Because the differential diagnosis is broad, patients should not draw conclusions on their own. Unilateral obstruction is often related to more common causes such as septal deviation, chronic rhinitis, or polyps; however, the picture changes when persistent bleeding, facial sensory change, or ocular symptoms accompany it. For that reason, assessment should not be limited to a simple “let’s try sinus medication and observe” approach; if clinical suspicion exists, further evaluation should be planned. A higher level of vigilance is warranted especially in adults with new unilateral symptoms. ^[1][3]

In summary, nasal and paranasal tumors are rare but clinically important conditions. Because their onset is often subtle, they may be mistaken for chronic sinusitis or allergy. Definitive diagnosis is established by biopsy, and treatment is individualized according to tumor type and stage. Persistent, unilateral, unexplained nasal and sinus symptoms warrant otolaryngologic evaluation. ^[1][2]

FAQ

Are nasal and paranasal tumors always cancer?

No. Benign, borderline, and malignant tumors may all occur in this region. However, if symptoms persist, physician assessment—and often tissue diagnosis—is needed to make the distinction. ^[1][2]

What is the most common symptom?

Unilateral nasal obstruction and nosebleeds are among the most notable symptoms. Facial pressure, discharge, smell changes, and symptoms around the eye may also occur. ^[1][3]

How is the diagnosis made?

Diagnosis is based on endoscopic examination, imaging, and biopsy used together. The definitive tumor type is determined by pathological review. ^[1][3]

What are the treatment options?

Surgery, radiotherapy, and chemotherapy are the main options. The appropriate combination is determined by tumor type, location, and stage. ^[1]

Which findings require urgent evaluation?

Rapidly increasing unilateral eye swelling, vision changes, significant bleeding, severe pain, or marked facial sensory loss may require urgent evaluation. ^[1][3]